T 0534/07 (CD8 T cells/OXXON THERAPEUTICS) vom 25.11.2008
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2008:T053407.20081125
- Datum der Entscheidung
- 25. November 2008
- Aktenzeichen
- T 0534/07
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 98928434.4
- IPC-Klasse
- C12N 15/30
- Verfahrenssprache
- Englisch
- Verteilung
- Nicht verteilt (D)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- Reagents for vaccination which generate a CD8 T cell immune response
- Name des Antragstellers
- Oxxon Therapeutics Limited
- Name des Einsprechenden
- Sanofi Pasteur
OXFORD BIOMEDICA (UK) LTD.
Therion Biologics Corporation
POWDERJECT VACCINES INC.
Danisco US Inc - Kammer
- 3.3.08
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 108 1973European Patent Convention Art 134(5) 1973European Patent Convention Art 54 1973European Patent Convention Art 54(3) 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973European Patent Convention R 65(1) 1973
- Schlagwörter
- Admissibility of appellant II's appeal - (no) - missing statement of grounds
Admissibility of appellant I's appeal - (yes)
Exclusion of representatives - (no) - no legal basis
Novelty - (yes)
Inventive step - (yes)
Sufficiency of disclosure (yes) - Orientierungssatz
- -
- Zitierende Akten
- -
ORDER
For these reasons it is decided that:
1. The appeal filed by the appellant PowderJect Vaccines Inc. is rejected as inadmissible.
2. The request filed by the appellant Danisco US, Inc. that the patent attorneys of Carpmaels and Ransford be excluded from further representing any of the parties in proceedings relating to the patent-in-suit EP 979 284 is rejected.
3. The decision under appeal is set aside.
4. The case is remitted to the opposition division with the order to maintain the patent with the claims of the main request of 24 October 2008, said claims having been filed as "First Auxiliary Request- amended", and a description and drawings to be adapted thereto.